AURKA and cancer: Using overexpression and downregulation through siRNA specifically against AurA approaches, we showed that AurA-E6 promoted hallmarks of cancer, including dysregulated cell cycle checkpoints, particularly at G1/S and mitotic phases of the cell cycle, as revealed by the expression of cyclin E and phosphor/acetylated-histone H3, respectively.